nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Cerebrovascular accident—Epirubicin—bone cancer	0.0021	0.0021	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Doxorubicin—bone cancer	0.0021	0.0021	CcSEcCtD
Fondaparinux sodium—Irritability—Methotrexate—bone cancer	0.0021	0.0021	CcSEcCtD
Fondaparinux sodium—Convulsion—Cisplatin—bone cancer	0.00209	0.00209	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Epirubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Anxiety—Cisplatin—bone cancer	0.00205	0.00205	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00204	0.00204	CcSEcCtD
Fondaparinux sodium—Hot flush—Doxorubicin—bone cancer	0.00203	0.00203	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Fondaparinux sodium—Renal impairment—Doxorubicin—bone cancer	0.002	0.002	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Fondaparinux sodium—Purpura—Doxorubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Oedema—Cisplatin—bone cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Cisplatin—bone cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Epirubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Fondaparinux sodium—Infection—Cisplatin—bone cancer	0.00195	0.00195	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Doxorubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Doxorubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Cisplatin—bone cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Cisplatin—bone cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Tachycardia—Cisplatin—bone cancer	0.00192	0.00192	CcSEcCtD
Fondaparinux sodium—Dehydration—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Fondaparinux sodium—Skin disorder—Cisplatin—bone cancer	0.00191	0.00191	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Cisplatin—bone cancer	0.0019	0.0019	CcSEcCtD
Fondaparinux sodium—Anorexia—Cisplatin—bone cancer	0.00188	0.00188	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Fondaparinux sodium—Hypotension—Cisplatin—bone cancer	0.00184	0.00184	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Cisplatin—bone cancer	0.00177	0.00177	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Cisplatin—bone cancer	0.00175	0.00175	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Cisplatin—bone cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Cisplatin—bone cancer	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—bone cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—bone cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Pain—Cisplatin—bone cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—bone cancer	0.00166	0.00166	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Cisplatin—bone cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—bone cancer	0.00161	0.00161	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—bone cancer	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—bone cancer	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Cisplatin—bone cancer	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—bone cancer	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Cisplatin—bone cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Asthenia—Cisplatin—bone cancer	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—bone cancer	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—bone cancer	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Cisplatin—bone cancer	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—bone cancer	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Vomiting—Cisplatin—bone cancer	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Rash—Cisplatin—bone cancer	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Dermatitis—Cisplatin—bone cancer	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Nausea—Cisplatin—bone cancer	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—bone cancer	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—bone cancer	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—bone cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—bone cancer	0.001	0.001	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—bone cancer	0.001	0.001	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—bone cancer	0.000994	0.000994	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—bone cancer	0.000992	0.000992	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—bone cancer	0.000991	0.000991	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—bone cancer	0.000989	0.000989	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—bone cancer	0.000986	0.000986	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—bone cancer	0.000981	0.000981	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—bone cancer	0.000977	0.000977	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—bone cancer	0.000976	0.000976	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—bone cancer	0.000975	0.000975	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—bone cancer	0.000972	0.000972	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—bone cancer	0.000969	0.000969	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000968	0.000968	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—bone cancer	0.000963	0.000963	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—bone cancer	0.000963	0.000963	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—bone cancer	0.00096	0.00096	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—bone cancer	0.00095	0.00095	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—bone cancer	0.000944	0.000944	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—bone cancer	0.000943	0.000943	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—bone cancer	0.000939	0.000939	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—bone cancer	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—bone cancer	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—bone cancer	0.000932	0.000932	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—bone cancer	0.000931	0.000931	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—bone cancer	0.000929	0.000929	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—bone cancer	0.000923	0.000923	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—bone cancer	0.00092	0.00092	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—bone cancer	0.000917	0.000917	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—bone cancer	0.000915	0.000915	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—bone cancer	0.000914	0.000914	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—bone cancer	0.000912	0.000912	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—bone cancer	0.000908	0.000908	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—bone cancer	0.000907	0.000907	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—bone cancer	0.000904	0.000904	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—bone cancer	0.000901	0.000901	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—bone cancer	0.000898	0.000898	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—bone cancer	0.000891	0.000891	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—bone cancer	0.00089	0.00089	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—bone cancer	0.000889	0.000889	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—bone cancer	0.000883	0.000883	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—bone cancer	0.000878	0.000878	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—bone cancer	0.000874	0.000874	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—bone cancer	0.000872	0.000872	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—bone cancer	0.000871	0.000871	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—bone cancer	0.000864	0.000864	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—bone cancer	0.000864	0.000864	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—bone cancer	0.000858	0.000858	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—bone cancer	0.000853	0.000853	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—bone cancer	0.000853	0.000853	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—bone cancer	0.000846	0.000846	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—bone cancer	0.000839	0.000839	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—bone cancer	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—bone cancer	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—bone cancer	0.000831	0.000831	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—bone cancer	0.000826	0.000826	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—bone cancer	0.000823	0.000823	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—bone cancer	0.000813	0.000813	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000807	0.000807	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—bone cancer	0.000806	0.000806	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—bone cancer	0.000803	0.000803	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—bone cancer	0.000795	0.000795	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—bone cancer	0.000775	0.000775	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—bone cancer	0.00077	0.00077	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—bone cancer	0.000764	0.000764	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—bone cancer	0.000764	0.000764	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—bone cancer	0.000744	0.000744	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—bone cancer	0.000743	0.000743	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—bone cancer	0.000739	0.000739	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—bone cancer	0.000739	0.000739	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—bone cancer	0.000739	0.000739	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—bone cancer	0.000725	0.000725	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—bone cancer	0.000715	0.000715	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—bone cancer	0.000714	0.000714	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—bone cancer	0.000691	0.000691	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—bone cancer	0.000689	0.000689	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—bone cancer	0.000686	0.000686	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—bone cancer	0.000681	0.000681	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—bone cancer	0.00068	0.00068	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—bone cancer	0.000676	0.000676	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—bone cancer	0.000671	0.000671	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—bone cancer	0.000668	0.000668	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—bone cancer	0.000661	0.000661	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—bone cancer	0.000642	0.000642	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—bone cancer	0.000641	0.000641	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—bone cancer	0.00064	0.00064	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—bone cancer	0.000637	0.000637	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—bone cancer	0.000636	0.000636	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—bone cancer	0.000633	0.000633	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—bone cancer	0.000618	0.000618	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—bone cancer	0.0006	0.0006	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—bone cancer	0.000594	0.000594	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—bone cancer	0.000589	0.000589	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—bone cancer	0.000589	0.000589	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—bone cancer	0.000586	0.000586	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—bone cancer	0.000555	0.000555	CcSEcCtD
